×
About 2,818 results

ALLMedicine™ Bacterial Pneumonia Center

Research & Reviews  835 results

Mortality and clinical cure rates for pneumonia: A systematic review, meta-analysis, an...
https://doi.org/10.1016/j.cmi.2021.12.021
Clinical Microbiology and Infection : the Official Public... Saleem N, Ryckaert F et. al.

Jan 17th, 2022 - Bactericidal antibiotics are generally assumed to be superior to bacteriostatic antibiotics as first-line treatment for pneumonia. We performed a systematic review, meta-analysis, and trial sequential analysis (TSA) of randomized controlled trials...

Improving CarE for Community Acquired Pneumonia
https://clinicaltrials.gov/ct2/show/NCT03760419

Jan 14th, 2022 - Pneumonia is the most common serious infection in childhood. In the United States (US), pneumonia accounts for 1-4% of all emergency department (ED) visits in children (3-28 per 1,000 US children per year) and ranks among the top 3 reasons for ped...

Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in C...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758006
PloS One; Atallah NJ, Warren HM et. al.

Jan 14th, 2022 - Coronavirus disease-2019 (COVID-19) is associated with a wide spectrum of clinical symptoms including acute respiratory failure. Biomarkers that can predict outcomes in patients with COVID-19 can assist with patient management. The aim of this stu...

Clinical sign and biomarker-based algorithm to identify bacterial pneumonia among outpa...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8735728
BMC Infectious Diseases; Hogendoorn SKL, Lhopitallier L et. al.

Jan 8th, 2022 - Inappropriate antibiotics use in lower respiratory tract infections (LRTI) is a major contributor to resistance. We aimed to design an algorithm based on clinical signs and host biomarkers to identify bacterial community-acquired pneumonia (CAP) a...

Compassionate-use pocapavir and immunoglobulin therapy for treatment of rituximab-assoc...
https://doi.org/10.1007/s13365-021-01038-z 10.1021/acsinfecdis.9b00179 10.1016/j.jaip.2015.12.015 10.1128/AAC.41.6.1220 10.1016/j.ejmech.2019.06.008 10.1016/j.pediatrneurol.2016.06.014 10.1053/jinf.2002.1066 10.1007/BF00918150 10.1016/S0022-3476(99)70246-5 10.1086/318452 10.1212/WNL.0000000000007468 10.1056/NEJM197706302962601 10.1128/AAC.00983-12
Journal of Neurovirology; Epstein S, Thakkar R et. al.

Jan 5th, 2022 - A 71-year-old woman previously on rituximab treatment for rheumatoid arthritis presented with 2 years of progressive neurologic symptoms. She was found to have persistent hypogammaglobulinemia and B cell depletion despite rituximab discontinuation...

see more →

Drugs  82 results see all →

Clinicaltrials.gov  37 results

Improving CarE for Community Acquired Pneumonia
https://clinicaltrials.gov/ct2/show/NCT03760419

Jan 14th, 2022 - Pneumonia is the most common serious infection in childhood. In the United States (US), pneumonia accounts for 1-4% of all emergency department (ED) visits in children (3-28 per 1,000 US children per year) and ranks among the top 3 reasons for ped...

Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016)
https://clinicaltrials.gov/ct2/show/NCT03583333

Jan 3rd, 2022 - This study will evaluate the efficacy and safety of imipenem/cilastatin/relebactam (IMI/REL) (MK-7655A) compared to piperacillin/tazobactam (PIP/TAZ) in the treatment of adults diagnosed with Hospital-Acquired Bacterial Pneumonia (HABP) or Ventila...

Study to Evaluate the PK of PO Omadacycline in Adults With Community-Acquired Bacterial Pneumonia
https://clinicaltrials.gov/ct2/show/NCT04160260

Nov 3rd, 2021 - The purpose of this study is to evaluate the pharmacokinetics of an oral omadacycline dosing regimen in the treatment of adults with CABP.

A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive Patients
https://clinicaltrials.gov/ct2/show/NCT00000947

Nov 3rd, 2021 - The need for MAC prophylaxis in advanced HIV disease is recognized. Prophylactic therapy is complicated, however, due to drug toxicity, potential drug interactions, patient noncompliance with multiagent regimens, microbial drug resistance, and hig...

OPEP Devices in Acute Inpatient Treatment of Pneumonia
https://clinicaltrials.gov/ct2/show/NCT04540510

Sep 24th, 2021 - Pneumonia is one of the most common health conditions leading to hospitalization today. Approximately 1.3 million people in the US are admitted to the hospital with community-acquired pneumonia (CAP) annually, with readmission rates within the fir...

see more →

News  169 results

Clinical Edge Journal Scan Commentary: CAP January 2022
https://www.mdedge.com/chestphysician/article/250325/community-acquired-pneumonia/clinical-edge-journal-scan-commentary-cap
Russell W. Steele, MD, MDedge News

Jan 2nd, 2022 - [[{"fid":"282102","view_mode":"medstat_image_flush_left","fields":{"format":"medstat_image_flush_left","field_file_image_caption[und][0][value]":"","field_file_image_caption[und][0][format]":"filtered_html","field_file_image_credit[und][0][value]".

High-Flow Surpasses Low-Flow Oxygen for COVID-19
https://www.medscape.com/viewarticle/964399

Dec 8th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. COVID-19 patients with severe disease were significantly less likely to require mechanical ventilation when treated with high-flow oxygen therapy ...

ERS 2021 — Incidence of Bacterial Pneumonia in the COVID-19 Era
https://www.medscape.com/viewarticle/958592

Sep 13th, 2021 - Takeaway The annual incidence of bacterial pneumonia treated at a secondary care centre in the UK fell by more than a third in 2020, when the COVID-19 pandemic began. The decline could be potentially attributed to reduced transmission of bacterial...

Doxycycline Not Helpful in Community Treatment of COVID-19
https://www.medscape.com/viewarticle/957045

Aug 24th, 2021 - NEW YORK (Reuters Health) - Community treatment with doxycycline did not reduce time to recovery or rates of hospital admission or death in patients with suspected COVID-19 who were at high risk of adverse outcomes, according to randomized trial f...

Three More Things We Do for No Reason in Pediatrics
https://www.medscape.com/viewarticle/949552

Apr 30th, 2021 - This transcript has been edited for clarity. Christopher J. Chiu, MD: Welcome back to The Cribsiders on Medscape. We are the pediatric medicine podcast, and on these videos we recap our interviews with leading experts in the field to bring you cli...

see more →

Patient Education  4 results see all →